Johnson & Johnson Other Comprehensive Income (Loss), Net of Tax
Johnson & Johnson (JNJ) reported Other Comprehensive Income (Loss), Net of Tax of $880.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-23
- Johnson & Johnson other comprehensive income (loss), net of tax for the quarter ending 2026-06-28 was $880.00M.
- Johnson & Johnson other comprehensive income (loss), net of tax for the quarter ending 2026-03-29 was $99.00M, a 9800.00% increase year-over-year.
- Johnson & Johnson other comprehensive income (loss), net of tax for the quarter ending 2025-12-28 was $307.00M, a 60.69% decline year-over-year.
- Johnson & Johnson other comprehensive income (loss), net of tax for the quarter ending 2025-09-28 was -$932.00M.
- Johnson & Johnson other comprehensive income (loss), net of tax for fiscal 2025 was -$3.19B, a 505.73% decline from fiscal 2024.
- Johnson & Johnson other comprehensive income (loss), net of tax for fiscal 2024 was $786.00M.
- Johnson & Johnson other comprehensive income (loss), net of tax for fiscal 2023 was -$4.74B, a 5309.89% decline from fiscal 2023.
- Johnson & Johnson other comprehensive income (loss), net of tax for fiscal 2023 was $91.00M, a 95.83% decline from fiscal 2022.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-28 | $880.00M 10-Q · filed 2026-07-23 | $979.00M 10-Q · filed 2026-07-23 | $1.29B derived: sum of 3 quarters · filed 2026-07-23 | $354.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-29 | $99.00M 10-Q · filed 2026-04-22 | $406.00M derived: sum of 2 quarters · filed 2026-04-22 | -$526.00M derived: sum of 3 quarters · filed 2026-04-22 | -$3.09B derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-28 | $307.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$625.00M derived: sum of 2 quarters · filed 2026-02-11 | -$3.19B derived: sum of 3 quarters · filed 2026-07-23 | -$3.19B 10-K · filed 2026-02-11 |
| 2025-09-28 | -$932.00M 10-Q · filed 2025-10-22 | -$3.50B derived: sum of 2 quarters · filed 2026-07-23 | -$3.50B 10-Q · filed 2025-10-22 | -$2.71B derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-29 | -$2.56B 10-Q · filed 2026-07-23 | -$2.56B 10-Q · filed 2026-07-23 | -$1.78B derived: sum of 3 quarters · filed 2026-07-23 | -$3.05B derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-30 | $1.00M 10-Q · filed 2026-04-22 | $782.00M derived: sum of 2 quarters · filed 2026-04-22 | -$487.00M derived: sum of 3 quarters · filed 2026-04-22 | -$972.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-29 | $781.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$488.00M derived: sum of 2 quarters · filed 2026-02-11 | -$973.00M derived: sum of 3 quarters · filed 2026-02-11 | $786.00M 10-K · filed 2026-02-11 |
| 2024-09-29 | -$1.27B 10-Q · filed 2025-10-22 | -$1.75B derived: sum of 2 quarters · filed 2025-10-22 | $5.00M 10-Q · filed 2025-10-22 | -$3.74B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$485.00M 10-Q · filed 2025-07-24 | $1.27B 10-Q · filed 2025-07-24 | -$2.47B derived: sum of 3 quarters · filed 2026-02-11 | -$2.75B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $1.76B 10-Q · filed 2025-04-23 | -$1.99B derived: sum of 2 quarters · filed 2026-02-11 | -$2.27B derived: sum of 3 quarters · filed 2026-02-11 | -$3.32B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$3.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$4.03B derived: sum of 2 quarters · filed 2026-02-11 | -$5.08B derived: sum of 3 quarters · filed 2026-02-11 | -$4.74B 10-K · filed 2026-02-11 |
| 2023-10-01 | -$278.00M 10-Q · filed 2024-10-23 | -$1.33B derived: sum of 2 quarters · filed 2024-10-23 | -$994.00M 10-Q · filed 2024-10-23 | $1.33B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-07-02 | -$1.06B 10-Q · filed 2024-07-25 | -$716.00M 10-Q · filed 2024-07-25 | $1.61B derived: sum of 3 quarters · filed 2025-02-13 | $160.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-04-02 | $341.00M 10-Q · filed 2024-05-01 | $2.67B derived: sum of 2 quarters · filed 2025-02-13 | $1.22B derived: sum of 3 quarters · filed 2025-02-13 | $1.13B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-01-01 | $2.33B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $876.00M derived: sum of 2 quarters · filed 2025-02-13 | $790.00M derived: sum of 3 quarters · filed 2025-02-13 | $91.00M 10-K · filed 2025-02-13 |
| 2022-10-02 | -$1.45B 10-Q · filed 2023-10-27 | -$1.53B derived: sum of 2 quarters · filed 2023-10-27 | -$2.23B 10-Q · filed 2023-10-27 | $123.00M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-07-03 | -$86.00M 10-Q · filed 2023-07-31 | -$785.00M 10-Q · filed 2023-07-31 | $1.57B derived: sum of 3 quarters · filed 2024-02-16 | $1.26B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-04-03 | -$699.00M 10-Q · filed 2023-04-28 | $1.66B derived: sum of 2 quarters · filed 2024-02-16 | $1.34B derived: sum of 3 quarters · filed 2024-02-16 | $1.57B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-01-02 | $2.36B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $2.04B derived: sum of 2 quarters · filed 2024-02-16 | $2.27B derived: sum of 3 quarters · filed 2024-02-16 | $2.18B 10-K · filed 2024-02-16 |
| 2021-10-03 | -$315.00M 10-Q · filed 2022-10-27 | -$87.00M derived: sum of 2 quarters · filed 2022-10-27 | -$173.00M 10-Q · filed 2022-10-27 | -$477.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-07-04 | $228.00M 10-Q · filed 2022-07-29 | $142.00M 10-Q · filed 2022-07-29 | -$162.00M derived: sum of 3 quarters · filed 2023-02-16 | $433.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-04-04 | -$86.00M 10-Q · filed 2022-04-29 | -$390.00M derived: sum of 2 quarters · filed 2023-02-16 | $205.00M derived: sum of 3 quarters · filed 2023-02-16 | $915.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-01-03 | -$304.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $291.00M derived: sum of 2 quarters · filed 2023-02-16 | $1.00B derived: sum of 3 quarters · filed 2023-02-16 | $649.00M 10-K · filed 2023-02-16 |
| 2020-09-27 | $595.00M 10-Q · filed 2021-10-29 | $1.30B derived: sum of 2 quarters · filed 2021-10-29 | $953.00M 10-Q · filed 2021-10-29 | $595.00M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-28 | $710.00M 10-Q · filed 2021-07-29 | $358.00M 10-Q · filed 2021-07-29 | $0.00 derived: sum of 3 quarters · filed 2022-02-17 | -$564.00M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-29 | -$352.00M 10-Q · filed 2021-04-30 | -$710.00M derived: sum of 2 quarters · filed 2022-02-17 | -$1.27B derived: sum of 3 quarters · filed 2022-02-17 | -$726.00M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-29 | -$358.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$922.00M derived: sum of 2 quarters · filed 2022-02-17 | -$374.00M derived: sum of 3 quarters · filed 2022-02-17 | -$669.00M 10-K · filed 2022-02-17 |
| 2019-09-29 | -$564.00M 10-Q · filed 2020-10-23 | -$16.00M derived: sum of 2 quarters · filed 2020-10-23 | -$311.00M 10-Q · filed 2020-10-23 | -$886.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $548.00M 10-Q · filed 2020-07-24 | $253.00M 10-Q · filed 2020-07-24 | -$322.00M derived: sum of 3 quarters · filed 2021-02-22 | -$192.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | -$295.00M 10-Q · filed 2020-04-29 | -$870.00M derived: sum of 2 quarters · filed 2021-02-22 | -$740.00M derived: sum of 3 quarters · filed 2021-02-22 | -$2.91B derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-30 | -$575.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$445.00M derived: sum of 2 quarters · filed 2021-02-22 | -$2.61B derived: sum of 3 quarters · filed 2021-02-22 | -$1.79B 10-K · filed 2021-02-22 |
| 2018-09-30 | $130.00M 10-Q · filed 2019-10-28 | -$2.04B derived: sum of 2 quarters · filed 2019-10-28 | -$1.22B 10-Q · filed 2019-10-28 | -$1.67B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-07-01 | -$2.17B 10-Q · filed 2019-07-29 | -$1.35B 10-Q · filed 2019-07-29 | -$1.80B derived: sum of 3 quarters · filed 2020-02-18 | -$1.31B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-04-01 | $823.00M 10-Q · filed 2019-05-01 | $371.00M derived: sum of 2 quarters · filed 2020-02-18 | $858.00M derived: sum of 3 quarters · filed 2020-02-18 | $2.15B derived: sum of 4 quarters · filed 2020-02-18 |
| 2017-12-31 | -$452.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $35.00M derived: sum of 2 quarters · filed 2020-02-18 | $1.32B derived: sum of 3 quarters · filed 2020-02-18 | $1.70B 10-K · filed 2020-02-18 |
| 2017-10-01 | $487.00M 10-Q · filed 2018-10-31 | $1.77B derived: sum of 2 quarters · filed 2018-10-31 | $2.15B 10-Q · filed 2018-10-31 | -$32.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-07-02 | $1.29B 10-Q · filed 2018-08-02 | $1.67B 10-Q · filed 2018-08-02 | -$519.00M derived: sum of 3 quarters · filed 2019-02-20 | -$527.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-04-02 | $379.00M 10-Q · filed 2018-05-01 | -$1.81B derived: sum of 2 quarters · filed 2019-02-20 | -$1.81B derived: sum of 3 quarters · filed 2019-02-20 | -$2.13B derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-01-01 | -$2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$2.19B derived: sum of 2 quarters · filed 2019-02-20 | -$2.51B derived: sum of 3 quarters · filed 2019-02-20 | -$1.74B 10-K · filed 2019-02-20 |
| 2016-10-02 | -$8.00M 10-Q · filed 2017-11-02 | -$324.00M derived: sum of 2 quarters · filed 2017-11-02 | $450.00M 10-Q · filed 2017-11-02 | $146.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-07-03 | -$316.00M 10-Q · filed 2017-08-03 | $458.00M 10-Q · filed 2017-08-03 | $154.00M derived: sum of 3 quarters · filed 2018-02-21 | -$653.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-04-03 | $774.00M 10-Q · filed 2017-05-08 | $470.00M derived: sum of 2 quarters · filed 2018-02-21 | -$337.00M derived: sum of 3 quarters · filed 2018-02-21 | $909.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-01-03 | -$304.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$1.11B derived: sum of 2 quarters · filed 2018-02-21 | $135.00M derived: sum of 3 quarters · filed 2018-02-21 | -$2.44B 10-K · filed 2018-02-21 |
| 2015-09-27 | -$807.00M 10-Q · filed 2016-11-04 | $439.00M derived: sum of 2 quarters · filed 2016-11-04 | -$2.14B 10-Q · filed 2016-11-04 | -$7.48B derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-28 | $1.25B 10-Q · filed 2016-08-04 | -$1.33B 10-Q · filed 2016-08-04 | -$6.67B derived: sum of 3 quarters · filed 2017-02-27 | -$9.05B derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-29 | -$2.58B 10-Q · filed 2016-05-10 | -$7.92B derived: sum of 2 quarters · filed 2017-02-27 | -$10.29B derived: sum of 3 quarters · filed 2017-02-27 | -$10.65B derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-28 | -$5.34B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$7.71B derived: sum of 2 quarters · filed 2017-02-27 | -$8.08B derived: sum of 3 quarters · filed 2017-02-27 | -$7.86B 10-K · filed 2017-02-27 |
| 2014-09-28 | -$2.38B 10-Q · filed 2015-10-30 | -$2.74B derived: sum of 2 quarters · filed 2015-10-30 | -$2.52B 10-Q · filed 2015-10-30 | -$36.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-29 | -$362.00M 10-Q · filed 2015-07-31 | -$147.00M 10-Q · filed 2015-07-31 | $2.34B derived: sum of 3 quarters · filed 2016-02-24 | $3.80B derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-30 | $215.00M 10-Q · filed 2015-05-01 | $2.70B derived: sum of 2 quarters · filed 2016-02-24 | $4.17B derived: sum of 3 quarters · filed 2016-02-24 | $4.04B derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-29 | $2.49B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $3.95B derived: sum of 2 quarters · filed 2016-02-24 | $3.83B derived: sum of 3 quarters · filed 2016-02-24 | $2.95B 10-K · filed 2016-02-24 |
| 2013-09-29 | $1.46B 10-Q · filed 2014-10-30 | $1.34B derived: sum of 2 quarters · filed 2014-10-30 | $464.00M 10-Q · filed 2014-10-30 | -$421.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$121.00M 10-Q · filed 2014-08-01 | -$1.00B 10-Q · filed 2014-08-01 | -$1.89B derived: sum of 3 quarters · filed 2015-02-24 | -$606.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$879.00M 10-Q · filed 2014-05-02 | -$1.76B derived: sum of 2 quarters · filed 2015-02-24 | -$485.00M derived: sum of 3 quarters · filed 2015-02-24 | -$2.15B derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-30 | -$885.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $394.00M derived: sum of 2 quarters · filed 2015-02-24 | -$1.27B derived: sum of 3 quarters · filed 2015-02-24 | -$178.00M 10-K · filed 2015-02-24 |
| 2012-09-30 | $1.28B 10-Q · filed 2013-11-04 | -$385.00M derived: sum of 2 quarters · filed 2013-11-04 | $707.00M 10-Q · filed 2013-11-04 | |
| 2012-07-01 | -$1.66B 10-Q · filed 2013-08-01 | -$572.00M 10-Q · filed 2013-08-01 | ||
| 2012-04-01 | $1.09B 10-Q · filed 2013-05-03 | |||
| 2012-01-01 | -$2.10B 10-K · filed 2014-02-21 | |||
| 2011-01-02 | -$473.00M 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |